Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$8.83M Buy
+300,000
New +$11.4M 0.07% 214
2016
Q1
Sell
-62,400
Closed -$3.15M 2362
2015
Q4
$3.15M Buy
62,400
+26,160
+72% +$1.33M 0.02% 667
2015
Q3
$1.74M Sell
36,240
-14,080
-28% -$733K 0.01% 958
2015
Q2
$2.62M Buy
+50,320
New +$2.83M 0.01% 784
2013
Q4
Sell
-40,000
Closed -$2.51M 2031
2013
Q3
$2.51M Buy
+40,000
New +$2.57M 0.02% 525

Other funds holding GSK

Jefferies Group's GSK Position: Q3 2022 in Review

Jefferies Group opened a new position in GSK (GSK) in Q3 2022: 298,662 shares worth $8.79M. The stake represents 0.07% of the portfolio and ranks #215 among its holdings. This is a return to the name: Jefferies Group previously reported a position in GSK as recently as Q4 2019.

Jefferies Group first reported a position in GSK in Q2 2013 and has held it in 16 quarters since. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Jefferies Group held 298,662 shares of GSK worth $8.79M as of Q3 2022.
  • GSK was a new Jefferies Group position in Q3 2022.
  • GSK made up 0.07% of Jefferies Group's portfolio in Q3 2022, its #215 holding.
  • Jefferies Group first reported a position in GSK in Q2 2013 and has held it in 16 quarters since.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.